Sign in and upgrade to a paid plan to export futures history as CSV.

Laxmi Dental Limited

Healthcare · Healthcare Equipment & Supplies

NSE: LAXMIDENTL BSE: 544339
₹191.42
▼ -1.07 (-0.56%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
60/100
Moderate
Valuation
17/100
Expensive
Momentum
13/100
Bearish

QVM read Mixed signals Quality Moderate, Valuation Expensive, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹1,052 Cr
PE (TTM)
59.4
Industry median 50.5 (7 companies)
Price to Book
4.3
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
40.99%
FII + DII, latest filed period
Piotroski Score
5
Relative return vs Nifty50, qtr %
-4.0
Relative return vs Sector, qtr %
-10.1
Free Cash Flow
₹-21 Cr
as of March 31, 2026
Industry median ₹-4 Cr (17 companies)
EPS Growth (YoY)
-21.68%
as of June 30, 2026
Industry median 27.06% (10 companies)
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
10.15%
as of June 30, 2026
Industry median 12.25% (11 companies)
Current Ratio
6.21
as of March 31, 2026
Industry median 3.04 (17 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.11 (12 companies)
Interest Coverage
22.24
as of June 30, 2026
Industry median 12.12 (11 companies)
Net Margin
Data unavailable.
Operating Margin (EBIT)
13.24%
as of June 30, 2026
Industry median 9.40% (11 companies)
Operating Margin (TTM)
9.33%
as of June 30, 2026
Industry median 13.81% (11 companies)
Return on Assets
9.84%
as of March 31, 2026
Industry median 4.45% (10 companies)
Return on Capital Employed
11.51%
as of March 31, 2026
Industry median 8.85% (11 companies)
Return on Equity
11.85%
as of March 31, 2026
Industry median 2.26% (9 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 6 met
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 5)
  • Yes Debt to equity is below 0.5 (0.00)
  • No Return on equity is 15% or more (11.8%)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

4 of 4 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

0 of 2 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median

Value and momentum

0 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Fair Value Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.6%
Low 190.3500 · High 196.9700
1W return
-1.9%
Low 190.3500 · High 201.5900
1M return
-2.1%
Low 189.4500 · High 205.0000
52W return
-41.6%
Low 155.8800 · High 344.8000
Lifetime High ₹550.5500 (Jan. 20, 2025)
Lifetime Low ₹158.2500 (March 30, 2026)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
193.5
10D
194.9
20D
196.6
50D
202.1
100D
207.4
200D
211.7

Delivery and volume

Day avg. delivery
59.8%
Week avg. delivery
57.8%
Month avg. delivery
57.1%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

192.91
Pivot
First resistance195.48
Second resistance199.53
Third resistance202.10
First support188.86
Second support186.29
Third support182.24
Day RSI39.1
Day MFI58.2
Day MACD-2.52
Day MACD signal-2.41

Beta

1M0.66
3M0.97
1Y1.27
3Y1.31

Price change analysis

↓ -2.1%
Over 1 Month
LowHigh
189.45205.00
↓ -14.1%
Over 3 Months
LowHigh
189.45234.00
↑ 7.9%
Over 6 Months
LowHigh
169.10275.49
↓ -41.6%
Over 1 Year
LowHigh
155.88344.80
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 59.4 (own history: 44.8–89.0)
Fair Value Zone
Revenue (June 30, 2026)
₹55 Cr
Net profit (June 30, 2026)
₹6 Cr
Basic EPS (June 30, 2026)
₹1.1200

Ranks #4 of 13 in Healthcare Equipment & Supplies by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter41.80%
  • Mutual funds10.11%
  • FII/FPI30.10%
  • Other DII0.78%
  • Public17.21%

Largest holders

NameCategoryShares %Shares
Orbimed Asia Ii Mauritius LimitedPublic22.4100%12317183
Rajesh Vrajlal KhakharPromoter16.9500%9317526
Sameer Kamlesh MerchantPromoter15.8300%8698111
Jigna Rajesh KhakharPromoter7.8400%4307444
Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) FundPublic4.6800%2571551

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings increased from 41.77% to 41.80% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 31.21% to 30.10% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings decreased from 10.32% to 10.11% in Jun 2026 qtr

7 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 5 insider trades, 5 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
1 Apr 2026 SAMEER KAMLESH MERCHANT Promoter Buy 0 ₹0
28 Feb 2026 SAMEER KAMLESH MERCHANT Promoter Buy 0 ₹0
23 Feb 2026 RAJESH VRAJLAL KHAKHAR Promoter Buy 0 ₹0
21 Feb 2026 RAJESH VRAJLAL KHAKHAR Promoter Buy 0 ₹0
21 Feb 2026 RAJESH VRAJLAL KHAKHAR Promoter Buy 0 ₹0

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
22 May 2026 NEO APEX SHARE BROKING SERVICES LLP Bulk Sell 342,346 249.2800 NSE
22 May 2026 NEO APEX SHARE BROKING SERVICES LLP Bulk Buy 342,346 247.6500 NSE
22 May 2026 MANSI SHARE AND STOCK BROKING PRIVATE LIMITED Bulk Sell 278,074 249.2800 NSE
22 May 2026 MANSI SHARE AND STOCK BROKING PRIVATE LIMITED Bulk Buy 278,074 248.9400 NSE
19 Feb 2026 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Sell 526,205 203.1100 NSE
19 Feb 2026 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Buy 526,205 202.9300 NSE
17 Sep 2025 JUNOMONETA FINSOL PRIVATE LIMITED Bulk Buy 356,223 360.9200 NSE
17 Sep 2025 JUNOMONETA FINSOL PRIVATE LIMITED Bulk Sell 356,223 361.1100 NSE
17 Sep 2025 HRTI PRIVATE LIMITED Bulk Buy 428,476 360.1400 NSE
17 Sep 2025 HRTI PRIVATE LIMITED Bulk Sell 415,826 360.8800 NSE

All bulk and block deals →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
11 Aug 2026 Financial Results Yes
21 May 2026 Financial Results Yes
10 Feb 2026 Financial Results Yes
11 Nov 2025 Financial Results Yes
12 Aug 2025 Financial Results/Other business matters Yes

Corporate Announcements

All 174 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
29 Sep 2026 Shareholders meeting Laxmi Dental Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 25, 2026. Further, the company has informed the Exchange regarding voting results.
29 Sep 2026 AGM/EGM Laxmi Dental Ltd - 544339 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
25 Sep 2026 Shareholders meeting Laxmi Dental Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 25, 2026
25 Sep 2026 Trading Window Laxmi Dental Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
25 Sep 2026 Insider Trading / SAST Laxmi Dental Ltd - 544339 - Closure of Trading Window
25 Sep 2026 AGM/EGM Laxmi Dental Ltd - 544339 - Shareholder Meeting / Postal Ballot-Outcome of AGM
23 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Laxmi Dental Limited has informed the Exchange about Schedule of meet
23 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Laxmi Dental Limited has informed the Exchange about Schedule of meet
18 Sep 2026 Company Update Laxmi Dental Ltd - 544339 - Intimation Of Approval For Listing And Trading Of Further Issue Of Equity Shares Under Laxmi Dental Employee Stock Option Scheme 2024
18 Sep 2026 General Updates Laxmi Dental Limited has informed the Exchange about General Updates

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (22.2x)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • PE above 35 (59.4) -- priced for continued strong execution
  • Down 41.6% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Laxmi Dental Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.